Madrigal Pharmaceuticals Cash Flow Statement (2010-2025) | MDGL

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	-52.82M	-61.65M	-63.10M	-64.55M	-57.52M	-70.73M	-81.20M	-85.91M	-76.90M	-85.80M	-98.74M	-112.19M	-147.54M	-151.97M	-106.96M	-59.42M	-73.24M	-42.24M	-111.12M	-58.45M
Share-based Compensation (Quarter)	6.10M	8.18M	6.24M	6.36M	7.48M	7.94M	8.12M	8.08M	11.25M	10.97M	12.66M	14.85M	19.90M	24.40M	17.90M	17.68M	20.93M	25.16M	26.25M	25.79M
Gains from Sales and Divestitures (Quarter)
Gains from Investment Securities (Quarter)											1.63M	-0.03M			1.17M	0.20M			-4.59M	4.59M
Non-cash Items (Quarter)
Cash from Operations (Quarter)	-43.43M	-46.88M	-45.56M	-48.05M	-49.91M	-57.36M	-59.07M	-58.52M	-84.07M	-75.31M	-84.92M	-79.93M	-149.16M	-134.94M	-66.98M	-104.49M	-88.89M	-47.05M	79.85M	-133.46M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter)						0.18M	0.31M	0.31M	0.43M	0.55M	0.67M	0.75M	0.66M	0.47M	0.48M	0.48M	0.44M	0.37M	0.33M	0.47M
Depreciation & Amortization (CF) (Quarter)	0.11M	0.09M	0.10M	0.11M	0.11M	0.11M	0.12M	0.13M	0.12M	0.13M	0.14M	0.14M	0.17M	0.27M	0.30M	0.36M	0.38M	0.38M	0.36M	0.39M
Change in Working Capital
Change in Receivables (Quarter)														6.90M	23.56M	23.36M	7.61M	17.80M	34.05M	21.19M
Change in Inventory (Quarter)													0.85M	6.22M	1.64M	25.35M	21.17M	8.26M	5.82M	1.73M
Change in Account Payables (Quarter)	3.38M	-3.33M	9.35M	10.96M	1.40M	-11.49M	7.27M	5.27M	-11.70M	5.41M	-0.99M	11.50M	-11.51M	-7.53M	36.97M	-2.37M	-1.54M	-4.08M	5.96M	4.94M
Change in Accured Expenses (Quarter)	-1.15M	11.16M	3.26M	-3.45M	-1.61M	18.39M	7.76M	11.86M	-5.89M	-3.81M	0.85M	7.37M	2.29M	23.34M	15.39M	-6.31M	-0.53M	33.31M	187.54M	-88.42M
Other Working Capital Changes (Quarter)	-0.19M	1.40M	1.59M	-2.47M	-0.12M	1.56M	1.14M	-1.32M	-0.79M	1.37M	-0.06M	0.03M	10.88M	0.93M	5.90M	-7.08M	9.46M	35.36M	-9.28M	-1.52M
Investing Activities
Capital Expenditures (Quarter)	0.04M	0.00M	0.05M	0.11M	0.05M	0.10M	0.03M	0.03M	0.04M	0.07M	0.34M	1.04M	0.36M	0.13M	0.78M	0.20M			0.73M	-0.26M
Change in Intangibles (Quarter)														5.00M					3.00M
Change in Acquisitions & Divestments (Quarter)	60.30M	103.03M	155.44M	70.50M	93.55M	98.27M	79.37M	79.20M	11.99M	88.21M	119.39M	113.80M	182.61M	163.82M	214.42M	302.43M	294.69M	273.39M	275.07M	240.15M
Cash from Investing Activities (Quarter)	-33.46M	-27.32M	40.09M	15.64M	55.93M	19.24M	65.14M	66.39M	-186.86M	-3.73M	50.20M	-362.12M	98.05M	-122.10M	-202.39M	-47.95M	163.88M	47.86M	-207.00M	27.58M
Financing Activities
Other financing activities (Quarter)						0.89M			0.21M	0.07M	0.07M									0.98M
Cash from Financing Activities (Quarter)	67.09M	63.54M	21.10M	19.50M		49.11M		264.34M	52.69M	42.93M	19.58M	479.92M	573.71M	134.12M	7.46M	19.77M	8.64M	1.74M	236.65M	8.96M
Additional items
Change in Cash (Quarter)	-9.80M	-10.66M	15.63M	-12.90M	6.01M	10.99M	6.07M	272.21M	-218.24M	-36.11M	-15.14M	37.86M	522.60M	-122.92M	-261.91M	-132.66M	83.63M	2.55M	109.50M	-96.91M
Free Cash Flow (Quarter)	-43.47M	-46.88M	-45.61M	-48.16M	-49.97M	-57.46M	-59.10M	-58.54M	-84.10M	-75.38M	-85.26M	-80.97M	-149.51M	-135.08M	-67.76M	-104.68M	-88.89M	-47.05M	79.12M	-133.20M
Net Cash Flow (Quarter)	-9.80M	-10.66M	15.63M	-12.90M	6.01M	10.99M	6.07M	272.21M	-218.24M	-36.11M	-15.14M	37.86M	522.60M	-122.92M	-261.91M	-132.66M	83.63M	2.55M	109.50M	-96.92M

Research Tools

Madrigal Pharmaceuticals Cash Flow Statement (2010-2025) | MDGL

Create an account

Sign In

Reset Password